Viatris shares fall nearly 3% as profit-taking and fading momentum pressure the stock

Viatris shares fall nearly 3% as profit-taking and fading momentum pressure the stock
Viatris slides 2.97% today to $17.13

Viatris Inc. (VTRS) fell 2.97% as profit-taking and a loss of early upside momentum weighed on the shares, even as better-than-expected sales and an improved full-year outlook were reported. The pullback finds some restraint, with the stock holding above its 50-day and 200-day moving averages despite short-term pressure below the 20-day average.

VTRS price prediction
24H 0.29%
$20.88
48H 0.72%
$20.97
7D 1.54%
$21.14
1M 8.79%
$22.65
3M 28.77%
$26.81
6M 40.83%
$29.32
12M 80.21%
$37.52
Current price: $20.82 0.1450 0.70%
Closed 11/13
Daily range 20.39 Arrow from to Icon 20.87
Weekly range 19.93 Arrow from to Icon 21.20
Loading...

Highlights

  • Viatris reported a second-quarter net loss of $118.8 million, significantly wider than the prior year's $4.6 million loss.
  • Full-year 2026 guidance was raised, with revenue now forecast at $14.55 billion to $14.95 billion and EPS at $2.45 to $2.59 despite persistent generics margin pressure.
  • Shares of Viatris are facing short-term selling pressure but maintain a bullish medium- and long-term structure, with a near-term trading range of $16.09 to $17.61 and upward bias favored.

Guidance revision and new launches counter sustained industry pricing pressure

Viatris Inc. reported a net loss of $118.8 million for the second quarter of 2026, compared to a net loss of $4.6 million in the same period last year, with a GAAP diluted loss per share of $0.10. The company delivered better-than-expected sales for the quarter and updated its 2026 full-year guidance, projecting revenue between $14.55 billion and $14.95 billion and earnings per share of $2.45 to $2.59. Ongoing price and margin challenges continued to pressure the generics business, while management cited planned new product launches, pipeline progress, and cost-saving initiatives as part of its long-term growth efforts, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, highlights that Viatris remains under short-term pressure despite beating sales expectations. He points out the rising net loss and ongoing margin challenges in the generics division as fundamental drawbacks. The technical structure is still positive over the medium term, but short-term signals, including loss of momentum below the 20-day average, suggest hesitation among buyers. Macroeconomic sentiment remains fragile, with broader market selling seen as a risk for further downside. "Investors should be wary of chasing bounces as any push below $16.94 would point to increased vulnerability in the current setup."
Viktoras Karapetjanc, expert at Traders Union, believes Viatris is positioned for further growth after delivering strong quarterly sales and increasing its guidance. He sees management's focus on new launches and cost initiatives as clear positives for long-term value creation. Technical factors also back up the case as the bullish structure above key moving averages remains intact. He notes that the market offers several positive setups, with a likely upward move toward $17.61 if resistance clears. "Growth prospects are robust, and I expect buyers to dominate if momentum breaks above $17.22 in the near term."
Sholanke Dele, market strategist, sees profit-taking and higher volatility as signs of tactical uncertainty. He is cautious given the widening net loss, which dampens confidence even after a headline beat. Market sentiment appears mixed, with short-lived upside giving way to session lows and intraday volatility at 9.19%. "Until buyers sustain a move above resistance, I remain skeptical about near-term recovery prospects for Viatris."
Viatris Inc asset chart
Viatris Inc price dynamics. Source: TradingView.

Bullish medium-term trend holds as short-term sellers test resistance

Viatris is trading below its 20-day moving average at $17.22 but remains above both the 50-day ($16.54) and 200-day ($14.06) moving averages. This suggests short-term seller pressure amid an intact bullish structure for the medium and long term. The nearest resistance is the 20-day moving average at $17.22, while the Ichimoku Kijun at $16.94 acts as support. Momentum indicators are mixed, with the MACD showing a Strong Buy signal, ADX neutral, and both RSI (59.76) and CCI (77.64) leaning bullish. Stochastic RSI and the Awesome Oscillator read neutral. Positive Bull/Bear Power (0.39) signals intraday buyer presence. The session tone is corrective after an initial upside gap and a retreat toward session lows, with intraday volatility at 9.19%.

Previously it was reported that Viatris maintained a constructive technical outlook supported by ongoing bullish signals. The current analysis adds that while the medium- and long-term structure remains favorable, traders should monitor the 20-day moving average at $17.22 as a key level that could trigger renewed upside if breached.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.